CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 15/3087% below fair value

$4.66−0.18 (-3.72%)

Close on Nov 13, 2026Market cap $363.22MP/E –Yield –

CorMedix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CorMedix's enterprise value was $154.94M on Nov 11, 2026, against $712.89M a year earlier. Over the last 5 years it ranged from $51.49M to $915.91M, with a median of $185.62M.

Enterprise Value at the end of each year

Period	Period end	Value	Change
2026	Nov 11, 2026	$154.94M	-81.9%
2025	Dec 31, 2025	$855.48M	+102.3%
2024	Dec 31, 2024	$422.86M	+253.8%
2023	Dec 29, 2023	$119.51M	+4.0%
2022	Dec 30, 2022	$114.90M	+13.7%
2021	Dec 31, 2021	$101.09M	-48.3%
2020	Dec 31, 2020	$195.69M	+27.0%
2019	Dec 31, 2019	$154.13M	-75.6%
2018	Dec 31, 2018	$630.82M	+341.9%
2017	Dec 29, 2017	$142.77M	-49.5%
2016	Dec 30, 2016	$282.45M	-12.1%
2015	Dec 31, 2015	$321.22M	+55.0%
2014	Dec 31, 2014	$207.29M	+110.5%
2013	Dec 31, 2013	$98.46M	+145.7%
2012	Dec 31, 2012	$40.08M	+206.4%
2011	Dec 30, 2011	$13.08M	–